glp-1 news today 2025 november 5 The Revolution Continues When Joshua Hunt (@viajoshhunt) started

Participants Raoul Manalac Senior Director of Scientific Affairs and External Evidence, Ro Amy Kane Health and Wellness Content Creator Michelle Look Medical Director, San Diego Sports Medicine Weight and Wellness Thomas Goetz Contributor, AtlanticLIVE speakers Pinchas Cohen Dean, USC Leonard Davis School of Gerontology Orian Shirihai Professor of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA Thomas Goetz Contributor, AtlanticLIVE Raoul Manalac Senior Director of Scientific Affairs and External Evidence, Ro Tyler Watson Executive Vice President of Marketing, The Atlantic Susan Sweeney Executive Vice President of Obesity and Related Conditions, Amgen Kevin Stephens Obesity Patient Advocate sponsor session Michelle Look Medical Director, San Diego Sports Medicine Weight and Wellness Amy Kane Health and Wellness Content Creator Katherine Saunders Co-Founder, FlyteHealth Ted Kyle Founder, ConscienHealth

Certain agents (liraglutide, injectable semaglutide, dulaglutide) have demonstrated cardiovascular benefits in high-risk patients with type 2 diabetes

Some patients benefit from dose pauses or temporary reductions, while others find anxiety subsides naturally within 6-8 weeks of consistent use

Fabrication "In Preparation" for Inspection: The lack of computer controls facilitated active fraud

Counterfeit and unregulated products may contain incorrect doses, contaminants, or no active ingredient at all

Schwartz, G